Drug interactions between Gilotrif and Tarceva
Interactions between your drugs
There were no interactions found in our database between Gilotrif and Tarceva - however, this does not necessarily mean no interactions exist. Always consult with your doctor or pharmacist.
- Gilotrif is in the drug class multikinase inhibitors.
- Gilotrif is used to treat Non-Small Cell Lung Cancer.
- Tarceva is a member of the drug class EGFR inhibitors.
- Tarceva is used to treat the following conditions:
Drug and food interactions
Applies to: Tarceva (erlotinib)
Erlotinib should be taken on an empty stomach 1 hour before or 2 hours after a meal and at the same time each day unless otherwise directed by your doctor. You should also avoid grapefruit and grapefruit juice while taking erlotinib. Food and grapefruit can raise the levels of erlotinib in your body and lead to increased side effects. Do not increase or decrease the amount of grapefruit products in your diet without first talking to your doctor.
Applies to: Gilotrif (afatinib)
Food may reduce the absorption of afatinib, which may lead to lower blood levels of the medication and possibly reduced effectiveness. You should take afatinib at least 1 hour before or 2 hours after a meal.
Therapeutic duplication warnings
No warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
Drug Interaction Classification
|Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.|
|Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.|
|Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.|
|No information available.|
Do not stop taking any medications without consulting your healthcare provider.